Financial Regulation

With a promising brain injury drug and no approved rivals, Oragenics heads to a tax-haven investor summit to secure funding for its next critical phase.

A new AI solution promises to automate a critical manufacturing step, tackling costly errors and downtime that plague the life sciences industry.

Crypto giant Bitwise lists seven diverse ETPs in Sweden, targeting tax-friendly ISK accounts and challenging established players in a heated European market.

TradeStation's new protocol lets traders talk to their accounts via AI, heralding a new era of conversational finance, but not without significant risks.

With new President Amanda Swoverland and CFO Francis Mitchell, Hatch Bank signals a major push to dominate the rapidly growing embedded finance market.

RAAPID’s award-winning Neuro-Symbolic AI brings transparency to risk adjustment, promising audit-ready accuracy and major ROI for value-based care.

Fintech leader Quavo appoints seasoned executives David Oldershaw and Tony DiGiorgio to accelerate growth and advance its AI-driven fraud-fighting platform.

The trading platform adds a third regulatory approval, bolstering its compliance framework and setting the stage for strategic expansion in Africa and Asia.

A wellness company is calling out the supplement industry, claiming many popular shilajit gummies are ineffective, candy-like products. Here's what's real.

The firm gives bondholders more time to trade near-term notes for a higher yield, sparking debate on strategy versus necessity in a tough market.

A new prop trading firm launches with an innovative model and a veteran leader. But Brian Ferdinand's recent personal bankruptcy adds a layer of risk.

With drug costs soaring, industry veteran Ritu Malhotra joins Illuminate Rx, promising to disrupt the opaque PBM market. But can transparency truly win?

A landmark OECD deal exempts US firms from a new 15% global tax, a major victory for over a million employee-owners whose retirement savings were at risk.

Maria Montenegro, an AI and M&A expert, takes the helm of the CP & ESG unit, signaling a major push into tech-driven corporate compliance and performance.

Prescryptive and Ilant Health unveil a direct-to-employer model for obesity drugs, promising transparent pricing and better clinical outcomes for employers.

Amid rising regulatory pressure, dxFeed's flawless performance in a critical industry-wide disaster recovery test sets a new benchmark for data reliability.

Riding a 50% revenue surge, Rhythm Pharmaceuticals faces a pivotal year with a major FDA decision and key clinical data for its rare obesity treatments.

In a move securing benefits for 400 retirees, Laurentian Bank transfers pension duties, reflecting a wider industry trend to reduce risk and simplify.

The diagnostics firm's new offering combines sample collection with CRO and CDMO services, aiming to slash timelines and reduce regulatory risk for developers.

A new study on oral testosterone therapy for men 65-80 could reshape geriatric care, challenge FDA guidelines, and unlock a multi-billion dollar market.